APO Research
Talk to an analyst

APO RESEARCH · REPORT

N-Acetylglutamate Synthetase Deficiency (NAGSD)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Growth and Trends Forecast to 2032

28 December 202586 pages

Choose your research edition.

Industry ResearchN-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Growth and Trends Forecast to 203286 pages · $3,450 USDMarket StructureGlobal N-Acetylglutamate Synthetase Deficiency (NAGSD) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

According to APO Research, the global N-Acetylglutamate Synthetase Deficiency (NAGSD) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for N-Acetylglutamate Synthetase Deficiency (NAGSD) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the N-Acetylglutamate Synthetase Deficiency (NAGSD) market include Grand Pharmaceutical Group, Lee's Pharmaceuticals, Sovereign Medical, Sigmapharm Laboratories, Recordati Rare Diseases, Medunik, Immedica, Amgen and Acer Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global N-Acetylglutamate Synthetase Deficiency (NAGSD) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The N-Acetylglutamate Synthetase Deficiency (NAGSD) market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global N-Acetylglutamate Synthetase Deficiency (NAGSD) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to N-Acetylglutamate Synthetase Deficiency (NAGSD).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global N-Acetylglutamate Synthetase Deficiency (NAGSD) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

N-Acetylglutamate Synthetase Deficiency (NAGSD) Market by Company

Grand Pharmaceutical Group

Lee's Pharmaceuticals

Sovereign Medical

Sigmapharm Laboratories

Recordati Rare Diseases

Medunik

Immedica

Amgen

Acer Therapeutics

N-Acetylglutamate Synthetase Deficiency (NAGSD) Segment by Type

Original Drug

Generic Drug

N-Acetylglutamate Synthetase Deficiency (NAGSD) Segment by Application

Adults

Children

N-Acetylglutamate Synthetase Deficiency (NAGSD) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global N-Acetylglutamate Synthetase Deficiency (NAGSD) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of N-Acetylglutamate Synthetase Deficiency (NAGSD) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of N-Acetylglutamate Synthetase Deficiency (NAGSD).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of N-Acetylglutamate Synthetase Deficiency (NAGSD) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2026) & (US$ Million) Table 3. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region (2021-2026) Table 4. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2027-2032) & (US$ Million) Table 5. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region (2027-2032) Table 6. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type (2021-2026) & (US$ Million) Table 8. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share by Type (2021-2026) Table 9. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share Forecasted by Type (2027-2032) Table 11. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application (2021-2026) & (US$ Million) Table 23. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share by Application (2021-2026) Table 24. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share Forecasted by Application (2027-2032) Table 26. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Trends Table 37. N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Drivers Table 38. N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Opportunities and Challenges Table 39. N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Restraints Table 40. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue by Company (US$ Million) & (2021-2026) Table 41. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue Market Share by Company (2021-2026) Table 42. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Key Company Headquarters & Area Served Table 44. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Company, Product Type & Application Table 45. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Grand Pharmaceutical Group Company Information Table 49. Grand Pharmaceutical Group Business Overview Table 50. Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 52. Grand Pharmaceutical Group Recent Development Table 53. Lee's Pharmaceuticals Company Information Table 54. Lee's Pharmaceuticals Business Overview Table 55. Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 57. Lee's Pharmaceuticals Recent Development Table 58. Sovereign Medical Company Information Table 59. Sovereign Medical Business Overview Table 60. Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 62. Sovereign Medical Recent Development Table 63. Sigmapharm Laboratories Company Information Table 64. Sigmapharm Laboratories Business Overview Table 65. Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 67. Sigmapharm Laboratories Recent Development Table 68. Recordati Rare Diseases Company Information Table 69. Recordati Rare Diseases Business Overview Table 70. Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 72. Recordati Rare Diseases Recent Development Table 73. Medunik Company Information Table 74. Medunik Business Overview Table 75. Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 77. Medunik Recent Development Table 78. Immedica Company Information Table 79. Immedica Business Overview Table 80. Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 82. Immedica Recent Development Table 83. Amgen Company Information Table 84. Amgen Business Overview Table 85. Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 87. Amgen Recent Development Table 88. Acer Therapeutics Company Information Table 89. Acer Therapeutics Business Overview Table 90. Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio Table 92. Acer Therapeutics Recent Development Table 93. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026) & (US$ Million) Table 95. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2026) Table 96. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share Forecast by Country (2027-2032) Table 98. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026) & (US$ Million) Table 100. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2026) Table 101. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share Forecast by Country (2027-2032) Table 103. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026) & (US$ Million) Table 105. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2026) Table 106. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share Forecast by Country (2027-2032) Table 108. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026) & (US$ Million) Table 110. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2026) Table 111. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share Forecast by Country (2027-2032) Table 113. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 114. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026) & (US$ Million) Table 115. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2026) Table 116. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 117. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share Forecast by Country (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Image Figure 3. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032) & (US$ Million) Figure 5. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region: 2025 VS 2032 Figure 6. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Region (2021-2032) Figure 7. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Original Drug Image Figure 13. Global Original Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Generic Drug Image Figure 15. Global Generic Drug Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Type 2025 VS 2032 Figure 18. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share by Type (2021-2032) Figure 19. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share by Type (2021-2032) Figure 21. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share by Type (2021-2032) Figure 23. Adults Image Figure 24. Global Adults Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Children Image Figure 26. Global Children Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Application 2025 VS 2032 Figure 29. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share by Application (2021-2032) Figure 30. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share by Application (2021-2032) Figure 32. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 N-Acetylglutamate Synthetase Deficiency (NAGSD) Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2032) Figure 39. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2032) Figure 42. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2032) Figure 45. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2032) Figure 48. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Adults
  • Children
Companies covered
  • Grand Pharmaceutical Group
  • Lee's Pharmaceuticals
  • Sovereign Medical
  • Sigmapharm Laboratories
  • Recordati Rare Diseases
  • Medunik
  • Immedica
  • Amgen
  • Acer Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2032)
  5. 1.4.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2021-2026)
  6. 1.4.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Region (2027-2032)
  7. 1.5 Key Regions N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size (2021-2032)
  8. 1.5.1 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (2021-2032)
2 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Original Drug
  3. 2.1.2 Generic Drug
  4. 2.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Type
  5. 2.2.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Regions
  9. 2.3.1 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Type (2021-2026)
3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Adults
  3. 3.1.2 Children
  4. 3.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Application
  5. 3.2.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Regions
  9. 3.3.1 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Trends
  2. 4.2 N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Drivers
  3. 4.3 N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Opportunities and Challenges
  4. 4.4 N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue (2021-2026)
  2. 5.2 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Key Company Headquarters & Area Served
  4. 5.4 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Company, Product Type & Application
  5. 5.5 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global N-Acetylglutamate Synthetase Deficiency (NAGSD) Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 N-Acetylglutamate Synthetase Deficiency (NAGSD) Players Market Share by Revenue in 2025
  9. 5.6.3 2025 N-Acetylglutamate Synthetase Deficiency (NAGSD) Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Grand Pharmaceutical Group
  2. 6.1.1 Grand Pharmaceutical Group Company Information
  3. 6.1.2 Grand Pharmaceutical Group Business Overview
  4. 6.1.3 Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Grand Pharmaceutical Group N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  6. 6.1.5 Grand Pharmaceutical Group Recent Developments
  7. 6.2 Lee's Pharmaceuticals
  8. 6.2.1 Lee's Pharmaceuticals Company Information
  9. 6.2.2 Lee's Pharmaceuticals Business Overview
  10. 6.2.3 Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Lee's Pharmaceuticals N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  12. 6.2.5 Lee's Pharmaceuticals Recent Developments
  13. 6.3 Sovereign Medical
  14. 6.3.1 Sovereign Medical Company Information
  15. 6.3.2 Sovereign Medical Business Overview
  16. 6.3.3 Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Sovereign Medical N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  18. 6.3.5 Sovereign Medical Recent Developments
  19. 6.4 Sigmapharm Laboratories
  20. 6.4.1 Sigmapharm Laboratories Company Information
  21. 6.4.2 Sigmapharm Laboratories Business Overview
  22. 6.4.3 Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sigmapharm Laboratories N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  24. 6.4.5 Sigmapharm Laboratories Recent Developments
  25. 6.5 Recordati Rare Diseases
  26. 6.5.1 Recordati Rare Diseases Company Information
  27. 6.5.2 Recordati Rare Diseases Business Overview
  28. 6.5.3 Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Recordati Rare Diseases N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  30. 6.5.5 Recordati Rare Diseases Recent Developments
  31. 6.6 Medunik
  32. 6.6.1 Medunik Company Information
  33. 6.6.2 Medunik Business Overview
  34. 6.6.3 Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Medunik N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  36. 6.6.5 Medunik Recent Developments
  37. 6.7 Immedica
  38. 6.7.1 Immedica Company Information
  39. 6.7.2 Immedica Business Overview
  40. 6.7.3 Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Immedica N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  42. 6.7.5 Immedica Recent Developments
  43. 6.8 Amgen
  44. 6.8.1 Amgen Company Information
  45. 6.8.2 Amgen Business Overview
  46. 6.8.3 Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Amgen N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  48. 6.8.5 Amgen Recent Developments
  49. 6.9 Acer Therapeutics
  50. 6.9.1 Acer Therapeutics Company Information
  51. 6.9.2 Acer Therapeutics Business Overview
  52. 6.9.3 Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Acer Therapeutics N-Acetylglutamate Synthetase Deficiency (NAGSD) Product Portfolio
  54. 6.9.5 Acer Therapeutics Recent Developments
7 North America
  1. 7.1 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026)
  3. 7.3 North America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026)
  3. 8.3 Europe N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026)
  3. 10.3 South America N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa N-Acetylglutamate Synthetase Deficiency (NAGSD) Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst